BRAC Lending Group LLC - 24 May 2021 Form 4/A - Amendment Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Reporting relationship: 10%+ Owner
Issuer ticker: NRXP
Reported as of: 24 May 2021
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 04 Jun 2021, 09:40:44 UTC
Original report date: 25 May 2021
Source filing: View source filing
Reporting owner signature: /s/ David M. Nussbaum. Managing Member

Key filing fact

BRAC Lending Group LLC filed Form 4/A - Amendment for NRX Pharmaceuticals, Inc. (NRXP) on 04 Jun 2021.

Key facts

This page summarizes BRAC Lending Group LLC's Form 4/A - Amendment filing for NRX Pharmaceuticals, Inc. (NRXP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Jun 2021, 09:40.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NRXP transaction

Common Stock

Disposed to Issuer

Transaction value: $0
Shares: -869,565
Change %: -60%
Price: $0.000000
Shares after: 590,435
Date: 24 May 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

BRAC Lending Group LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Form 4 filed on May 25, 2021, erroneously reported 562,435 shares beneficially owned in Column 5. This amendment is being filed to correct the total shares beneficially owned in Column 5.